FDA Inspection 953135 — Jubilant HollisterStier General Partnership

Jubilant HollisterStier General Partnership — FEI 3001623073

The FDA completed an inspection of Jubilant HollisterStier General Partnership on December 10, 2015 in Kirkland. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 10, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kirkland (Canada)